SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation
2 clinical trials · Condition
◉ Watch SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation
| Record | Firm | Date |
|---|---|---|
| AVTX-801 D-galactose Supplementation in SLC35A2-CDG (NCT05402384) | Eva Morava-Kozicz | 2027-01-01 |
| Galactose Supplementation for the Treatment of MOGHE (NCT04833322) | Hospital Ruber Internacional | 2021-01-15 |
Track SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation automatically
Every clearance here is in the API, with alerts when new ones post.